mRNA |
Dasatinib |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0005 |
mRNA |
MS-275 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0006 |
mRNA |
SU11274 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.0007 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0008 |
mRNA |
PD-0325901 |
CCLE |
pan-cancer |
AAC |
-0.15 |
0.0008 |
mRNA |
narciclasine |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.0008 |
mRNA |
Midostaurin |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0009 |
mRNA |
SR-II-138A |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.0009 |
mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.001 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.001 |